Also known as آسٹیوپوروسس مینجمنٹ
Gastroenterologist
M.B.B.S, F.C.P.S
Gastroenterologist
MBBS, MD, MACG (USA)
Internal Medicine Specialist
M.B.B.S., F.C.P.S. (Medicine)
Internal Medicine Specialist
MBBS, Specialty Certificate in Endocrine and Diabetes, MRCP (Dublin), MRCP (London)
Internal Medicine Specialist
MBBS, Specialty Certificate in Endocrine and Diabetes, MRCP (Dublin), MRCP (London)
Rheumatologist
MBBS, FCPS (Medicine), FCPS ( Rheumatology), CHPE , FRCP
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Internal Medicine Specialist
M.B.B.S., F.C.P.S. (Medicine), Fellowship in Pulmonology, Fellowship in Critical Care Medicine
Internal Medicine Specialist
M.B.B.S., F.C.P.S. (Medicine), Fellowship in Pulmonology, Fellowship in Critical Care Medicine
Internal Medicine Specialist
M.B.B.S., F.C.P.S., MRCP (UK), Fellow Rheumatology
Diabetologist
MBBS, FCPS , MRCP, MRCP (UK), SCE Endocrinology and Diabetes (UK)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures